Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

Eli Lilly’s Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lilly ...

A major change to her prescription benefits meant the medication she was using to manage her weight – a treatment that ... different set of broader indications, with Zepbound also approved to treat ...

A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others. Should you?

LLY has slid 15.7% over the past year, but surging demand for Mounjaro and Zepbound could revive the stock's momentum.

The two drugs have a different set of broader indications, with Zepbound also approved to treat sleep apnea in people with obesity, for example.

And in a candid conversation with PEOPLE, Ginger opens up for the first time about her weight loss journey, the health scare ...

Expect social and relationships to change after weight loss. The more weight you lose and the more you change your lifestyle to achieve healthy weight loss, the more likely relationships are to change ...

CVS Caremark will stop covering the weight management drug Zepbound, leading to concerns over prescription benefits and insurance coverage for obesity treatments.